Skip to content

Home
About Synthonics
Synthonics in the Press
Contact

Home
About Synthonics
Synthonics in the Press
Contact

Synthonics to Begin Clinical Trial of Extended Release T3

May 21, 2022

https://www.biospace.com/article/synthonics-to-begin-clinical-trial-of-extended-release-t3/

Categories Press Releases

Sustained Release T3 Therapy: Animal Models and Translational Applications

Controlled Release of Liothyronine (LT3) Shown in First Clinical Trial of PolyZincLiothyronine (PZL)

Synthonics Inc.

Metal Coordinated Pharmaceuticals

Contact

2200 Kraft Drive, Suite 2225,
Blacksburg, VA, 24060

540.443.3645

[email protected]

Join The Synthonics Newsletter

Join our newsletter to stay up to date on all things Synthonics!

Leave this field empty if you're human:

© 2022 Synthonics, Inc.

Home
About Synthonics
Synthonics in the Press
Contact